Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng

Abtahi, Shahab; Driessen, Johanna H M; Burden, Andrea M; Souverein, Patrick C; van den Bergh, Joop P; van Staa, Tjeerd P; Boonen, Annelies; de Vries, Frank

doi:https://doi.org/10.1136/annrheumdis-2021-219856

Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng

DSpace/Manakin Repository

Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng

Abtahi, Shahab; Driessen, Johanna H M; Burden, Andrea M; Souverein, Patrick C; van den Bergh, Joop P; van Staa, Tjeerd P; Boonen, Annelies; de Vries, Frank

(2023) Annals of the Rheumatic Diseases, volume 82, issue 4

(Letter)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Keywords: epidemiology, glucocorticoids, osteoporosis, rheumatoid arthritis, Taverne, Rheumatology, Immunology and Allergy, Immunology, General Biochemistry,Genetics and Molecular Biology

DOI: https://doi.org/10.1136/annrheumdis-2021-219856

ISSN: 0003-4967

Publisher: BMJ Publishing Group

(Peer reviewed)

See more statistics about this item